Six-year Follow-Up and Subgroup Analyses of a Phase 2 Trial of Venetoclax for Del(17p) Chronic Lymphocytic Leukemia.
Stephan Stilgenbauer,Eugen Tausch,Andrew W. Roberts,Matthew S. Davids,Barbara Eichhorst,Michael Hallek,Peter Hillmen,Christof Schneider,Johannes Schetelig,Sebastian Boettcher,Arnon P. Kater,Yanwen Jiang,Michelle Boyer,Relja Popovic, Majd T. Ghanim, Michael Moran,Wendy J. Sinai,Xifeng Wang,Nabanita Mukherjee,Brenda Chyla,William G. Wierda,John F. Seymour Blood Advances（2024）
AI 理解论文
溯源树
样例
